Two-step targeting and dosimetry for small cell lung cancer xenograft with anti-NCAM/antihistamine bispecific antibody and radioiodinated bivalent hapten

Journal of Nuclear Medicine

Volumn 40, Issue 7, 1999, Pages 1216-1221

  Hosono, Makoto ^a   Hosono, Masako N ^b   Kraeber Bodéré, Françoise ^b   Devys, Anne ^b   Thédrez, Philippe ^b   Faivre Chauvet, Alain ^b   Gautherot, Emmanuel ^b   Barbet, Jacques ^b   Chatal, Jean François ^b  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b NONE

Author keywords

Affinity enhancement system; Antineural cell adhesion molecule antihistamine bispecific antibody; Pretargeting; Small cell lung carcinoma

Indexed keywords

ANTIHISTAMINIC AGENT; BISPECIFIC ANTIBODY; HAPTEN; IMMUNOGLOBULIN F(AB) FRAGMENT; MONOCLONAL ANTIBODY NK1 NBL 1 679; NERVE CELL ADHESION MOLECULE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DOSIMETRY; DRUG BLOOD LEVEL; DRUG LIVER LEVEL; DRUG TARGETING; DRUG TUMOR LEVEL; KIDNEY; LUNG SMALL CELL CANCER; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOIODINATION; TUMOR XENOGRAFT;

EID: 0032976378     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Le Doussal J, Gruaz-Guyon A, Martin M, Delaage M, Barbet J. Targeting of indium-111-labeled bivalent hapten to human melanoma mediated by bispecific monoclonal antibody conjugates: imaging of tumors hosted in nude mice. Cancer Res. 1990;50:3445-3452.
2. Le Doussal JM, Chetanneau A, Gruaz-Guyon A, et al. Bispecific monoclonal antibody-mediated targeting of an indium-111-labeled DTPA dimer to primary colorectal tumors: pharmacokinetics, biodistribution, scintigraphy and immune response. J Nucl Med. 1993;34:1662-1671.
3. 111In-labelled bivalent hapten and a bispecific antibody conjugate. Nucl Med Commun. 1994;15:972-980.
4. Peltier P, Curtet C, Chatal JF, et al. Radioimmunodetection of medullary thyroid cancer using a bispecific anti-CEA/anti-indium-DTPA antibody and an indium-111-labeled DTPA dimer. J Nucl Med. 1993;34:1267-1273.
5. Vuillez JP, Moro D, Brichon PY, et al. Two-step immunoscintigraphy for non-small-cell lung cancer staging using a bispecific anti-CEA/anti-indium-DTPA antibody and an indium-111-labeled DTPA dimer. J Nucl Med. 1997;38:507-511.
6. Souhami RL, Law K. Longevity in small cell lung cancer. A report to the lung cancer subcommittee of the United Kingdom Committee for Cancer Research. Br J Cancer. 1990;61:584-589.
7. 131I-labelled monoclonal antibody. Br J Cancer. 1988;58:292-295.
8. 131I-labelled SWA11 antibody. Br J Cancer. 1991;64:263-266.
9. 186Re radioimmunotherapy of small cell lung carcinoma xenografts in nude mice. Cancer Res. 1991;51:676-681.
10. Hosono M, Endo K, Hosono NM, et al. Treatment of small cell lung cancer xenografts with iodine-131-anti-neural cell molecule monoclonal antibody and evaluation of absorbed dose in tissue. J Nucl Med. 1994;35:296-300.
11. Takahashi T, Ueda R, Song X, et al. Two novel cell surface antigens on small cell lung carcinoma defined by mouse monoclonal antibodies NE-25 and PE-35. Cancer Res. 1986;46:4770-4775.
12. Bardiès M, Bardet S, Faivre-Chauvet A, et al. Bispecific antibody and iodine-131-labeled bivalent hapten dosimetry in patients with medullary thyroid or small-cell lung cancer. J Nucl Med. 1996;37:1853-1859.
13. Said JW, Nash G, Tepper G, Banks-Schlegel S. Keratin proteins and carcinoembryonic antigen in lung carcinoma: an immunoperoxidase study of 54 cases with ultrastructural correlations. Hum Pathol. 1983;14:70-76.
14. Moolenaar CECK, Muller EJ, Schol DJ, et al. Expression of neural cell adhesion molecule-related sialoglycoprotein in small cell lung cancer and neuroblastoma cell lines H69 and CHP-212. Cancer Res. 1990;50:1102-1106.
15. Morel A, Darmon M, Delaage M. Recognition of imidazole and histamine derivatives by monoclonal antibodies. Mol Immunol. 1990;27:995-1000.
16. Bast RC, Feeney M, Lazarus H, Nadler LM, Colvin RB, Knapp RC. Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest. 1981;68: 1331-1337.
17. Janevik-Ivanovska E, Gautherot E, Hillairet de Boisferon M, et al. Bivalent hapten-bearing peptides designed for iodine-131 pretargeted radioimmunotherapy. Bioconjug Chem. 1997;8:526-533.
18. Gazdar AF, Camey DN, Russell EK, et al. Establishment of continuous, clonable cultures of small-cell carcinoma of the lung which have amine precursor uptake and decarboxylation cell properties. Cancer Res. 1980;40:3502-3507.
19. Yuan F, Baxter LT, Jain RK. Pharmacokinetic analysis of two-step approaches using bifunctional and enzyme-conjugated antibodies. Cancer Res. 1991;51:3119-3130.
20. Berger MU. Distribution of absorbed dose around point sources of electrons and beta particles in water and other media. Medical Internal Radiation Dose (MIRD) Pamphlet No. 7. J Nucl Med. 1971;(suppl 5):7-23.
21. Buchegger F, Chalandon Y, Pèlegrin A, Hardman N, Mach JP. Bone marrow dosimetry in rats using direct tissue counting after injection of radioiodinated intact monoclonal antibodies or F(ab′)2 fragments. J Nucl Med. 1991;32:1414-1421.
22. Holst BD, Wang Y, Jones FS, Edelman GM. A binding site for Pax proteins regulates expression of the gene for the neural cell adhesion molecule in the embryonic spinal cord. Proc Natl Acad Sci. 1997;94:1465-1470.
23. Hosono M, Hosono MN, Kraeber-Bodere F, et al. Biodistribution and dosimetric study in medullary thyroid cancer xenograft using bispecific antibody and iodine-125-labeled bivalent hapten. J Nucl Med. 1998;39:1608-1613.
24. 131I-radiolabeled murine monoclonal antibody in a human glioma xenograft model. Cancer Res. 1988;48:559-566.
25. Ornadel D, Ledermann JA, Eagle K, et al. Biodistribution of a radiolabelled monoclonal antibody NY3D11 recognizing the neural cell adhesion molecule in tumour xenografts and patients with small-cell lung cancer. Br J Cancer. 1998;77:103-109.
26. Kwa HB, Wesseling J, Verhoeven AH, van Zandwijk N, Hilkens J. Immunoscintigraphy of small-cell lung cancer xenografts with anti neural cell adhesion molecule monoclonal antibody, 123C3: improvement of tumour uptake by internalisation. Br J Cancer. 1996;73:439-446.